Core Insights - Danone is restructuring its operations into three new geographical zones: EMEA, Americas, and APAC, effective from January 1, 2026, which will impact its reporting structure and key performance indicators [2][12] - The company will disclose sales for former regions while continuing to report by product category [3] Sales Performance - The restated sales figures for 2024 and 2025 by geographical zone indicate a total sales of €27.376 billion in 2024 and €27.283 billion in 2025 [5] - EMEA sales are projected to grow from €11.952 billion in 2024 to €12.212 billion in 2025, while Americas sales are expected to decline from €9.608 billion to €9.108 billion [5] - APAC sales are anticipated to increase from €5.816 billion in 2024 to €5.963 billion in 2025 [5] Like-for-Like Sales Growth - EMEA's like-for-like sales growth for 2025 shows a change of +3.9% for the full year, with quarterly growth rates ranging from +2.0% to +4.6% [6] - The Americas region exhibits a full-year growth of +3.2%, with quarterly fluctuations including a decline of -0.5% in Q2 2025 [6] - APAC demonstrates strong growth with a full-year increase of +7.6%, peaking at +10.2% in Q2 2025 [6] Category Performance - Essential Dairy & Plant-based (EDP) category sales are projected to be €13.158 billion in 2025, with a like-for-like growth of +3.5% [9] - Specialized Nutrition is expected to achieve €9.277 billion in sales for 2025, reflecting a +7.4% growth [9] - Waters category sales are forecasted to be €4.848 billion in 2025, with a modest growth of +1.9% [9] Recurring Operating Income and Margin - The recurring operating income for EMEA is projected to be €1.349 billion in 2025, maintaining a margin of 11.0% [10] - Americas' recurring operating income is expected to reach €904 million in 2025, with a margin improvement to 9.9% [10] - APAC is anticipated to have a recurring operating income of €1.412 billion in 2025, with a margin of 23.7% [10]

Core Insights - The company reported strong and consistent growth in Q3 2025, with consolidated sales reaching €6,876 million, reflecting a 4.8% increase on a like-for-like basis, driven primarily by volume/mix growth of 3.2% and price growth of 1.6% [6][10][14] Sales Performance by Geography - **Europe**: Sales increased by 2.6% on a like-for-like basis, with volume/mix contributing 2.1% and positive price growth of 0.5%. This marks eight consecutive quarters of positive volume/mix growth [8][10] - **North America**: Sales grew by 1.5% on a like-for-like basis, with volume/mix contributing 0.3% and price growth of 1.2%. High protein products maintained strong momentum [9][10] - **China, North Asia & Oceania**: Outstanding performance with sales up 13.8% on a like-for-like basis, driven by a volume/mix increase of 15.1% [10][11] - **Latin America**: Sales increased by 4.3% on a like-for-like basis, despite a volume/mix decline of 2.3% [11] - **Asia, Middle East & Africa**: Sales growth accelerated to 6.8% on a like-for-like basis, with volume/mix contributing 2.6% [12] Sales Performance by Category - **EDP (Essential Dairy Products)**: Sales were up 3.5% on a like-for-like basis, with notable growth in functional dairy products [8][10] - **Specialized Nutrition**: Achieved 8.3% growth on a like-for-like basis, with double-digit growth in adult medical nutrition [8][10] - **Waters**: Sales increased by 2.3% on a like-for-like basis, with strong growth driven by brands like evian [8][10] Strategic Developments - The company confirmed its 2025 guidance, expecting like-for-like sales growth between 3% and 5%, with recurring operating income anticipated to grow faster than sales [14] - Recent acquisitions, including Kate Farms, are expected to enhance the company's portfolio in the plant-based nutrition segment [20]

Core Viewpoint - The company has reported a strong start to 2025 with a like-for-like (LFL) sales growth of +4.3%, indicating the effectiveness of its health-oriented portfolio and execution strategy [3][4]. Group 1: First Quarter Sales Performance - Total sales for Q1 2025 reached €6,844 million, reflecting a +4.3% increase on a like-for-like basis, driven by a +1.9% increase in volume/mix and a +2.4% increase in price [4]. - Reported sales increased by +0.8%, impacted negatively by a scope change of -3.0% due to the sale of Horizon Organic and Wallaby, and a forex impact of -0.8% [4][5]. - The company experienced broad-based growth across all categories, with particularly strong performance in China, North Asia & Oceania, and solid growth in North America and Europe [4][6][7][8]. Group 2: Sales by Geography - In Europe, LFL sales grew by +2.0%, supported by a +1.9% increase in volume/mix, achieving positive growth momentum for six consecutive quarters [6]. - North America saw LFL sales increase by +3.7%, driven by strong performance in High Protein products and Medical Nutrition [7]. - China, North Asia & Oceania reported LFL sales growth of +9.9%, with significant contributions from Specialized Nutrition and Waters [8]. - Latin America experienced LFL sales growth of +9.0%, primarily led by the Aptamil brand in Specialized Nutrition [9]. - The Rest of the World had LFL sales growth of +3.3%, with notable performance in EDP and Specialized Nutrition [10]. Group 3: 2025 Guidance and Recent Developments - The company has confirmed its 2025 guidance, expecting LFL sales growth between +3% and +5%, with recurring operating income anticipated to grow faster than sales [12]. - Recent developments include a completed share buyback of €192 million and a successful bond issuance of €800 million, reflecting strong investor confidence in the company's business model [13][14].